Ex vivo B cell depletion using the Eligix B Cell SC system and autologous peripheral blood stem cell transplantation in patients with follicular non-Hodgkin's lymphoma (Q44586688)

From Wikidata

Jump to navigation Jump to search

scientific article published in October 2003

Language	Label	Description	Also known as
English	Ex vivo B cell depletion using the Eligix B Cell SC system and autologous peripheral blood stem cell transplantation in patients with follicular non-Hodgkin's lymphoma	scientific article published in October 2003

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Ex vivo B cell depletion using the Eligix B Cell SC system and autologous peripheral blood stem cell transplantation in patients with follicular non-Hodgkin's lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

author name string

Friedberg JW

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Kim H

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Li S

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Neuberg D

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Boyd K

5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Daley H

6

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Fisher DC

7

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Gribben JG

8

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Spitzer T

9

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Freedman AS

10

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

language of work or name

0 references

publication date

1 October 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

681-686

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704212

21 January 2018

Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704212

21 January 2018

Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704212

21 January 2018

High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704212

21 January 2018

High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704212

21 January 2018

Bcl-2 clearance: optimising outcomes in follicular non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704212

21 January 2018

Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704212

21 January 2018

Effective purging of autologous hematopoietic stem cells using anti-B-cell monoclonal antibody-coated high-density microparticles prior to high-dose therapy for patients with non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704212

21 January 2018

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704212

21 January 2018

Autologous bone marrow transplantation after histologic transformation of indolent B cell malignancies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704212

21 January 2018

The impact of external beam radiation therapy prior to autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704212

21 January 2018

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704212

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704212

21 January 2018

IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704212

21 January 2018

Is total body irradiation a necessary component of preparative therapy for autologous transplantation in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704212

21 January 2018

In vivo purging and relapse prevention following ASCT.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704212

21 January 2018

A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and non-toxic treatment for advanced follicular and mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704212

21 January 2018

High-dose therapy and stem cell transplantation in follicular lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704212

21 January 2018

Outcome of high-dose therapy and autologous transplantation in non-Hodgkin's lymphoma based on the presence of tumor in the marrow or infused hematopoietic harvest

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704212

21 January 2018

The natural history of initially untreated low-grade non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704212

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704212

7 January 2021

based on heuristic

inferred from DOI database lookup

Lack of correlation between numbers of circulating t(14;18)-positive cells and response to first-line treatment in follicular lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704212

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: long-term clinical and molecular follow-up

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704212

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation in refractory Hodgkin's disease and non-Hodgkin's lymphoma: a dose-finding study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704212

7 January 2021

based on heuristic

inferred from DOI database lookup

Engraftment and molecular monitoring of CD34+ peripheral-blood stem-cell transplants for follicular lymphoma: a pilot study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704212

7 January 2021

based on heuristic

inferred from DOI database lookup

Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: results of a multicenter randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704212

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous stem cell transplantation for non-Hodgkin's lymphoma: comparison of radiation-based and chemotherapy-only preparative regimens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704212

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab in vivo purging is safe and effective in combination with CD34-positive selected autologous stem cell transplantation for salvage therapy in B-NHL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704212

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunotherapy with rituximab during peripheral blood stem cell transplantation for non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704212

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1704212

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44586688&oldid=2206764697"